Table 2.

Assessment of Articles Reporting Use of Treatment Fidelity Strategies (n = 755)

NIH BCC treatment fidelity strategy checklist	n	%	Medication, %		p
			No, n = 249	Yes, n = 506
Treatment design
1. Provided information about treatment dose in the intervention condition(s)	755	96.3	96.0	96.4	.754
Length of contact session(s)	755	59.3	54.0	62.1	.030
Number of contacts	755	76.0	71.6	78.3	.040
Content of treatment	755	88.0	92.4	85.8	.009
Duration of contact over time	755	87.3	84.8	88.5	.141
2. Provided information about treatment dose in the control or comparison condition	755	84.0	85.6	83.2	.410
Length of contact session	755	43.2	35.6	47.0	.002
Number of contacts	755	56.7	54.0	58.1	.264
Content of treatment	755	74.3	76.8	73.1	.289
Duration of contact over time	755	71.3	69.2	72.3	.353
3. Mention of provider credentials	690	63.1	70.0	60.2	.016
4. Mention of theoretical model or clinical guidelines	755	62.4	73.6	56.9	<.001
5. Mention of potential confounders that limit the ability to make conclusions	755	81.1	86.4	78.5	.009
6. Mention of plans to address possible setbacks in implementation	755	5.2	4.8	5.3	.763
7. More than one intervention is described, they all described equally well	414	81.8	81.4	82.1	.858
Training providers
1. Indication of how providers were trained	689	23.3	29.2	20.8	.017
2. Indication that provider training was standardized	689	21.3	22.9	20.7	.519
3. Measurement of provider skill acquisition post training (pre-field implementation)	689	7.4	10.0	6.3	.085
4. Indication of how provider skills were maintained	689	24.7	24.2	24.9	.839
5. A priori articulation of the characteristics being sought in a treatment provider	689	6.7	5.2	7.3	.317
6. Assessment of fit between the provider and the intervention at the hiring stage	689	1.9	1.0	2.3	.237
Delivery of treatment
1. Method to ensure that the content of the intervention was being delivered as specified	755	24.2	27.3	22.7	.167
2. Method to ensure that the dose of the intervention was being delivered as specified	755	15.2	14.5	15.6	.678
3. Mechanism to assess if the provider actually adhered to the intervention plan	689	21.1	22.6	20.4	.502
4. Non-specific treatment effects (eg perceived warmth) evaluated	688	2.6	2.4	2.7	.784
5. Authors indicate that a treatment manual was used	688	32.1	30.5	32.8	.546
6. Authors indicate a plan for assessment of whether active ingredients were delivered	755	16.4	16.9	16.2	.817
7. Authors indicate a plan for assessment of whether proscribed components were excluded	755	7.8	8.4	7.5	.657
8. Authors indicate a plan for how will contamination between conditions be prevented	700	12.4	14.6	11.4	.220
9. Authors indicate a priori specification of treatment fidelity	755	10.9	16.9	7.9	<.001
10. Authors indicate any post-activation adaptations or modifications in treatment delivery	755	9.3	14.9	6.5	<.001
Receipt of treatment
1. Subject comprehension of the intervention assessed during the intervention period	755	6.6	7.6	6.1	.435
2. Strategy to improve subject comprehension of the intervention	755	5.2	4.8	5.3	.763
3. Subject ability to perform the intervention skills assessed during the intervention period	755	44.2	44.2	44.3	.981
4. Strategy to improve subject performance of intervention skills during the intervention period	755	9.8	8.8	10.3	.531
5. Multi-cultural factors considered in the development and delivery of the intervention	755	13.8	13.6	13.8	.946
Enactment of treatment skills
1. Subject performance of the intervention skills assessed	755	43.0	42.2	43.5	.733
2. Strategy to improve subject performance of the intervention	755	6.6	6.0	6.9	.643

Boldface indicates statistical significance (p ≤ .05).